Navigate to Other Instruments
CLColgate-Palmolive
Colgate-Palmolive
CLHow can you trade Colgate-Palmolive? Colgate-Palmolive (CL) is publicly listed. On CoinUnited, eligible users can trade a CL stock CFD — price exposure that tracks the share price. It is a price CFD, not equity (no shareholder voting; dividends reflected as an adjustment) — with leverage, from US$100. Access terms vary by jurisdiction and product eligibility.
How to trade it
Trading Regime Status
How the CL CFD works
Before you trade, understand exactly what you get, what you don't, and where the risk sits.
Price exposure to the CL reference (a synthetic CFD) that tracks the CoinUnited reference up and down.
It is not equity: no shares, no voting rights; dividends are reflected as an adjustment, not paid to you.
The CoinUnited reference tracks the share price but can differ from the exchange price; extended-hours liquidity is thinner.
Trading conditions on CoinUnited
Fee schedule as of 2026-08-19| Product type | CFD | Synthetic price exposure. You do not hold the underlying asset. |
|---|---|---|
| Trading fee | 0.070% | Per side, at the standard tier. Falls with 30-day volume and reaches 0.000% at VIP 9. |
| Trading hours | Market session | Follows the market session and is closed at weekends and on market holidays. |
| Leverage — intraday | 800x | During active trading hours. Requires 0.063% margin at the smallest position size. Availability and the maximum depend on product, jurisdiction and account eligibility; leverage amplifies losses and positions can be liquidated. |
| Leverage — overnight | 10x | For a position held beyond the trading day. Requires 5.000% margin at the smallest position size. |
| Leverage — weekends & holidays | 10x | For a position held through a market closure. Requires 5.000% margin at the smallest position size — check your position size before carrying it into a weekend. |
| Direction | Long or short | Take a position in either direction. A short position profits when the price falls and loses when it rises. |
| Funding | Crypto deposit | Fund and withdraw in crypto. No bank transfer or card is required. |
Trading Colgate-Palmolive CFDs on CoinUnited.io
A CoinUnited CL position is a contract for difference (CFD): it provides leveraged price exposure that tracks Colgate-Palmolive's underlying equity price, but it does not convey shareholding, voting rights, or entitlement to dividends. The mechanics are purely price-based, the position gains or loses value as the underlying market moves, scaled by the leverage multiple applied.
How Price Exposure Works
The CFD mirrors the CL equity price tick-for-tick. If the underlying stock rises 1%, a leveraged position captures that 1% move multiplied by the leverage in use, generating proportionally larger gains, and equally larger losses, relative to the margin posted. The maximum leverage available on the CoinUnited CL instrument is 800x, subject to product terms, jurisdiction, and account eligibility.
At that multiple, a 0.125% adverse move against an 800x position equals 100% of the initial margin, illustrating how rapidly losses can accumulate. The specification is included here as a risk reference, not as an invitation to use the maximum.
Worked position-size example (hypothetical):
| Parameter | Value |
|---|---|
| Margin posted | $500 |
| Leverage applied | 200x |
| Notional exposure | $100,000 |
| Underlying move | +2% |
| Gross P&L | +$2,000 |
| Underlying move | −2% |
| Gross P&L | −$2,000 |
The example uses 200x, well within the instrument maximum. The arithmetic is straightforward: margin × multiple = notional; notional × percentage move = P&L. Sizing a position based on notional exposure rather than nominal margin posted is the operationally correct approach for this instrument.
What Drives Intraday Behavior
CL's intraday price action is shaped by several recurring factors. Quarterly earnings releases are the highest-impact scheduled events: the stock can open significantly above or below the prior session's close following a report, especially when results diverge materially from consensus estimates.
As of Q2 2026, Colgate-Palmolive reported net revenue of $5.36 billion, up 4.9% year over year, and base-business EPS of $0.99, up 8% year over year, results of that magnitude relative to expectations can produce sustained directional moves lasting multiple sessions.
Beyond earnings, intraday movement responds to: broad consumer staples sector flows, US dollar strength (given Colgate's international revenue exposure), commodity cost data affecting input costs such as raw materials and packaging, and macroeconomic releases including inflation and consumer confidence figures.
With the US 10-year Treasury yield at 4.77% as of early September 2026, the interest-rate environment also bears on dividend-sensitive stocks like CL, as yield shifts alter the relative attractiveness of dividend-paying equities.
Session Structure and Gap Risk
The CL CFD follows a scheduled trading session. It is closed at weekends and observes market holidays. The precise session hours and holiday calendar are shown on the platform before any trade is placed, consult these before sizing a position.
The closed-session structure creates gap risk at every open, and that risk is highest over weekends. Any macro announcement, geopolitical development, or sector news released between Friday's close and Monday's open cannot be acted upon until the session resumes. Positions held over the weekend carry that unhedged exposure for the full duration of the closure.
Earnings releases that coincide with or fall close to session closures compound this effect.
For CL specifically, the relatively lower historical volatility profile, compared with technology equities or cryptocurrency instruments, can create a false sense of security around gap sizing.
Leveraged positions amplify even modest gap moves into significant margin events.
Trading Fees
CoinUnited charges a trading fee on the CL market. Fees are not zero at the standard tier; they are tiered across VIP levels by 30-day contract volume. The applicable rate is displayed on the platform before any trade is confirmed. The full fee schedule is published at https://coinunited.io/en/account/trading-fees.
Traders who execute frequently should review the schedule to understand how cumulative volume affects per-trade costs, as fee drag can meaningfully affect net returns on tightly-managed positions.
Ready to Trade CL?
Up to 800x leverage
Key facts & how to trade
Access & Tradability Comparison
A CoinUnited stock CFD vs holding the underlying shares — how, when, and in what form you get exposure. The stock price is everywhere; this comparison is the differentiator.
| Terms | CoinUnited (CFD) | Holding shares (exchange) |
|---|---|---|
| Product form | Stock CFD (price exposure) | Equity ownership |
| Trading hours | Market session | Exchange regular hours |
| Leverage | Available (by product terms) | None / margin account needed |
| Shareholder rights | None (no voting; dividends as adjustment) | Voting + dividends |
| Access | Eligible users, by region + product | Brokerage account required |
*Access and minimum vary by jurisdiction and product eligibility.
Key Facts
The most-cited facts about this company, each with its source — the quick-reference box for readers and AI answer engines.
Primary source: Wikidata
| Founded | 1953 |
|---|---|
| Headquarters | New York City |
| CEO | Noel Wallace |
| Industry | personal care product |
| Listing status | Publicly listed: CLExchange |
| Market cap | $70B (as of 2026-09-20)CoinUnited reference x SEC shares |
| P/E | ~33.3CoinUnited reference / SEC annual EPS |
| 52-week range | $74.53 – $99.31CoinUnited daily kline |
| Next earnings | 2026-10-30Finnhub |
| CoinUnited product | Stock CFD — price exposure, not equity (no voting; dividends reflected as adjustment); leverage availableCoinUnited product terms |
Price & Market Structure
Company & financials
What Is Colgate-Palmolive (CL)?
TL;DR
Colgate-Palmolive is a large-cap consumer staples company with a globally recognized oral-care and home-care portfolio, high institutional ownership, consistent dividend growth, and a defensive earnings profile that attracts both income-oriented and stability-seeking traders.
Colgate-Palmolive is a multinational consumer staples corporation headquartered in New York, operating across oral care, personal care, home care, and pet nutrition segments.
Its product portfolio spans some of the most widely recognised household brands globally, including Colgate toothpaste, toothbrushes, and mouthwash, Palmolive dish and body products, Ajax cleaners, Softsoap hand and body wash, and Hill's Pet Nutrition, a prescription and science-based pet food line.
The breadth of this portfolio positions the company as a diversified consumer goods business rather than a single-category operator.
Business Model and Revenue Profile
Colgate-Palmolive generates revenue primarily through the mass-market retail channel, selling branded, high-frequency consumables that households repurchase on short cycles. This structure, volume-driven, brand-protected, and geographically distributed, is characteristic of defensive consumer staples companies.
The repeat-purchase nature of categories such as toothpaste and dish soap provides relatively stable cash flows across economic conditions.
As of Q2 2026, the company reported net revenue of $5.36 billion, up 4.9% year over year. Base-business earnings per share reached $0.99 in the same quarter, an 8% increase year over year, reflecting both top-line growth and operational discipline.
The gross profit margin expanded 140 basis points year over year to 61.5% in Q2 2026, consistent with a branded-goods model that sustains pricing power even in cost-pressured environments.
Dividend Profile and Institutional Ownership
Colgate-Palmolive raised its quarterly dividend from $0.52 to $0.53 per share in 2026, equating to an annualized rate of $2.12 per share. This increase extends a multi-decade record of consecutive annual dividend raises, placing the company within the cohort commonly referred to as Dividend Aristocrats, large-cap equities that have grown dividends for at least 25 consecutive years.
Institutional investors held approximately 80.41% of outstanding shares as of mid-2026, according to MarketBeat. BlackRock alone held approximately 69.9 million shares, or roughly 8.74% of the company, as of June 30, 2026. This concentration of institutional ownership reflects the stock's role in defensive, income-oriented equity portfolios.
Market Classification
CL is classified within the consumer staples sector of the S&P 500, a benchmark that stood at 7,718.60 as of early September 2026. Consumer staples companies are broadly considered defensive large-cap equities: demand for their core products tends to be less sensitive to economic cycles than discretionary goods, which draws allocations during periods of elevated market uncertainty.
The VIX volatility index registered 14.32 as of early September 2026, reflecting a relatively contained volatility environment at the time.
Traders researching how CL fits within the broader equity landscape may find the 2026 Stocks Market Outlook useful for contextualising sector rotation and macroeconomic conditions affecting consumer staples.
CoinUnited Instrument Note
On CoinUnited, exposure to Colgate-Palmolive is taken via a CFD position that tracks the price of the underlying equity. This confers no shareholding, voting rights, or entitlement to dividends, it is price exposure only.
The instrument follows a scheduled trading session and is closed at weekends and on market holidays; session details and the holiday calendar are shown on the platform before you trade. Trading fees apply and are not zero at the standard tier; the full tiered fee schedule is available at coinunited.io/en/account/trading-fees.
Last updated: 2026-09-07
Key Insights
- Colgate-Palmolive's Q2 2026 gross profit margin reached 61.5%, expanding 140 basis points year over year, reflecting pricing power and cost discipline in a competitive consumer staples environment.
- Institutional investors held approximately 80.41% of Colgate-Palmolive shares as of mid-2026, including BlackRock's roughly 8.74% stake, indicating deep long-term ownership concentration that can dampen intraday volatility but amplify moves during institutional rebalancing.
- The company's mid-single-digit base-business EPS growth guidance for 2026, paired with a dividend raised to $0.53 per quarter, positions CL as a classic capital-preservation name rather than a growth-momentum play.
- First-half 2026 free cash flow before dividends of $1.48 billion against $879 million in dividends paid illustrates the company's capacity to sustain its dividend without straining liquidity.
- Consumer staples names such as CL typically exhibit lower beta relative to the broader market, making them reference points for traders seeking defensive exposure during periods of elevated macro uncertainty.
Key Financials
Audited · SEC filingsReported figures from the company’s latest SEC filings — each linked to its source filing and period.
Quarterly revenue
~ Q4 is not filed as a standalone quarter — it is the annual 10-K figure minus the three filed quarters.
Figures are from the company’s audited SEC filings; each carries its filing source and period. Not investment advice.
CL's Competitive Position in Consumer Staples
Colgate-Palmolive occupies a distinct position within the consumer staples sector: it is the dominant global brand in toothpaste and broader oral care, while also competing across personal care, home care, and pet nutrition.
Understanding where it sits relative to its principal peers, Procter & Gamble and Unilever, gives traders a framework for assessing relative-value dynamics and sector-rotation decisions.
Oral Care: A Concentrated Competitive Moat
Oral care is Colgate-Palmolive's core segment and the category where its competitive advantage is most concentrated. The primary rival in this segment is Procter & Gamble, whose Crest and Oral-B brands represent the main alternative in developed markets.
Despite competing against a company with a substantially larger overall revenue base and a broader product scope, Colgate has historically maintained leading market share in toothpaste across many geographies, particularly in emerging markets where dental hygiene penetration continues to grow from a lower base.
This dynamic, a narrower category focus yielding deeper brand loyalty, is one reason analysts treat CL's oral-care exposure as a durable competitive asset rather than a concentrated risk.
The emerging-market angle matters for traders tracking long-term revenue trajectory. Colgate has invested heavily in building distribution and brand recognition in markets across Latin America, Africa, and Asia, where rising incomes tend to increase per-capita spending on personal care products.
This gives the oral-care segment a structural growth component that is less dependent on volume expansion in saturated developed markets.
Procter & Gamble: The Primary Large-Cap Benchmark
For relative-value analysis, Procter & Gamble is the most natural large-cap comparison. P&G's revenue base is larger and its product scope substantially wider, spanning beauty, grooming, health, fabric, home, and baby care alongside oral care. That breadth means P&G is generally more diversified by category, while CL's narrower focus creates a purer-play exposure to oral-care demand trends.
Traders rotating within consumer staples often use the CL-versus-P&G spread to express views on category-specific demand or geographic growth.
Unilever: Cross-Segment Overlap
Unilever competes with Colgate-Palmolive across home-care and personal-care categories, where both companies maintain comparable product lines in dish care, surface cleaning, and body wash. The overlap is meaningful but partial.
Colgate's Hill's Pet Nutrition division has no direct Unilever equivalent, providing a distinct revenue stream tied to premium pet food demand, a category with its own demand dynamics, including recurring veterinarian-recommended prescription diets. That separation offers earnings diversification that pure-play peer comparisons may underweight.
Institutional Ownership and Index Dynamics
With approximately 80.41% of shares held by institutional investors as of mid-2026, according to MarketBeat, CL's shareholder base closely resembles those of P&G and other large-cap staples peers. BlackRock alone held approximately 8.74% of the company as of June 30, 2026.
This concentration in pension funds, index funds, and large asset managers stabilizes the stock under normal conditions but also means that CL's price is sensitive to broad index rebalancing flows, particularly those driven by S&P 500 sector weight shifts, rather than purely company-specific catalysts.
Analyst Sentiment and Valuation Debate
Analyst sentiment around CL in the period leading into September 2026 tilted positive following the Q2 2026 earnings result, in which revenue grew 4.9% year over year to $5.36 billion and base-business EPS rose 8% year over year to $0.99. The raised profit outlook reinforced the defensive earnings quality case.
The ongoing debate, common across the consumer staples sector and visible in the 2026 Stocks Market Outlook, centres on whether CL's premium valuation relative to the broader market is justified by its earnings stability, or whether that premium compresses during risk-on environments when capital rotates toward higher-growth sectors.
Traders monitoring sector rotation should track that valuation spread, as it tends to widen during periods of elevated market uncertainty and narrow when risk appetite recovers.
Why Trade CL? Investment Thesis and Key Drivers
Colgate-Palmolive's investment thesis rests on a combination of defensive earnings characteristics, consistent capital return, and exposure to global consumer demand, offset by currency risk, valuation sensitivity, and limited upside in high-growth environments. Understanding these forces is essential for any trader taking a CFD position on CL.
Defensive Classification and Risk-Off Rotation
CL sits within the consumer staples sector, where demand for core products, toothpaste, dish soap, hand wash, is relatively inelastic. Households continue purchasing these items through recessions, credit tightening, and equity drawdowns. This earnings stability makes CL a frequent destination for capital rotating out of cyclical sectors during risk-off episodes.
When broader equity volatility rises, institutional allocators often increase defensive exposure, which can support CL's relative price performance even as the wider market declines.
This dynamic is worth framing precisely: CL does not typically lead bull markets. Its appeal is resilience, not acceleration. Traders positioning for aggressive upside in a risk-on environment may find more velocity elsewhere; those seeking a defensive anchor or a short-volatility expression within equities often look to names like CL.
Earnings Catalysts
Quarterly earnings releases are the primary near-term price catalyst for CL. As of Q2 2026, the company reported revenue of $5.36 billion, up 4.9% year over year, and base-business EPS of $0.99, up 8% year over year. Management's guidance for mid-single-digit base-business EPS growth for full-year 2026 established a constructive baseline for the remainder of the year.
Traders active around earnings should monitor whether organic volume growth, pricing contribution, and gross margin trajectory are tracking above or below these signals.
The broader 2026 Stocks Market Outlook provides useful context for how macro conditions, including the current rate environment, with the 10-year Treasury yield at 4.77% as of early September 2026, interact with large-cap consumer staples earnings multiples.
Currency Risk
Colgate-Palmolive generates a material portion of revenue outside the United States. USD strength compresses reported results even when local-currency performance is healthy, because overseas revenue translates back at less favorable rates. This structural sensitivity means that positioning on CL implicitly includes a view on the dollar.
During periods of pronounced USD appreciation, reported revenue and EPS figures can lag underlying operational performance, creating a gap between business fundamentals and headline numbers.
Valuation and Multiple Risk
Consumer staples companies, including CL, frequently trade at premium multiples relative to cyclicals. This premium reflects the defensive earnings profile and dividend consistency described above.
The risk is compression: if organic growth decelerates, margin expansion stalls, or the rate environment shifts in ways that make income-oriented equities less attractive relative to fixed income, the valuation premium can erode without a corresponding earnings miss.
Traders should treat CL's entry point relative to historical multiples as a relevant risk variable, not just an earnings-per-share story.
Capital Return and Free Cash Flow
First-half 2026 free cash flow before dividends reached $1.48 billion. Colgate-Palmolive raised its quarterly dividend from $0.52 to $0.53 per share in 2026, representing an annualized rate of $2.12 per share.
This combination of strong free cash flow generation and consistent dividend growth supports price stability during market drawdowns, institutional holders with income mandates are less likely to rotate out of a stock with a rising dividend covered by robust cash flow.
The trade-off is that capital allocated to dividends and buybacks is not deployed into high-growth initiatives. CL's return profile is characteristically different from technology or high-growth consumer names such as Sea Limited, where reinvestment drives the thesis rather than current yield.
Traders should calibrate return expectations accordingly: CL offers relative stability and income-linked support, not exponential growth optionality.
Summary of Key Drivers
| Driver | Direction of Impact | Key Variable to Watch |
|---|---|---|
| Defensive rotation demand | Positive in risk-off environments | VIX, sector flows |
| Earnings momentum | Positive when above guidance | Organic growth, EPS vs. consensus |
| USD strength | Negative for reported results | DXY, FX translation disclosures |
| Valuation multiple | Headwind if growth decelerates | P/E relative to staples peers |
| Dividend and FCF | Price-anchoring, limits drawdown depth | FCF conversion, payout ratio |
No single factor dominates in isolation. CL's price at any given point reflects the interaction of these forces, and a trader's edge comes from assessing which of them is the marginal driver at the current moment in the cycle.
Valuation & peers
Peer Valuation Comparison
How this stock trades versus comparable listed companies on trailing valuation multiples.
| Company | Market cap | P/E | P/S |
|---|---|---|---|
| Colgate-Palmolive · CL | $69.5B | 34.1x | 3.3x |
| Monster Beverage Corporation · MNST | $84.9B | 39.8x | 9.2x |
| Mondelez International, Inc. · MDLZ | $79.7B | 23.0x | 2.0x |
| Diageo plc · DEO | $48.2B | 27.8x | 2.5x |
| Coca-Cola Europacific Partners PLC · CCEP | $45.5B | 19.9x | 1.8x |
| The Kroger Co. · KR | $35.8B | 31.3x | 0.2x |
Third-party ratios (FMP), trailing twelve months. Multiples vary by data window; a negative or absent P/E means the company is loss-making. Not investment advice.
Analyst Price Targets
HoldWall Street sell-side analysts’ consensus 12-month price target and rating for this stock.
Targets by firm
Latest target from each of the 9 firms whose call was reported in the past 180 days. Each row links to the report.
| Firm | Target | vs current |
|---|---|---|
| RBC Capital2026-08-03 · TheFly | $104.00 | +20.0% |
| Deutsche Bank2026-08-03 · TheFly | $101.00 | +16.6% |
| Morgan Stanley2026-08-03 · TheFly | $104.00 | +20.0% |
| UBS2026-08-03 · TheFly | $109.00 | +25.8% |
| Wells Fargo2026-07-08 · TheFly | $95.00 | +9.6% |
| Bernstein2026-06-11 · TheFly | $96.00 | +10.8% |
| Redburn Partners2026-04-21 · TheFly | $100.00 | +15.4% |
| Barclays2026-04-14 · TheFly | $79.00 | -8.8% |
| Piper Sandler2026-04-08 · TheFly | $92.00 | +6.2% |
Source: aggregated sell-side analyst consensus · as of 2026-09-13. These are third-party analyst opinions — not CoinUnited’s view, not a price prediction, and not investment advice.
Scenario calculator
Pick a third-party reference level and see what it implies at leverage. Reference levels only - not a CoinUnited forecast.
Simplified: excludes fees, funding and slippage. Reference levels are third-party marks (CoinUnited daily kline; aggregated sell-side analyst targets), not forecasts. Leverage magnifies losses as much as gains - at high leverage a small adverse move liquidates the position. Not investment advice.
Catalysts & news
Catalyst Timeline
Dated third-party developments that move the stock — newest first, each classified bullish or bearish and linked to its source.
- 2026-10-30Next quarterly earnings◆ ScheduledNext scheduled quarterly earnings report (2026-10-30). Revenue, margins and guidance are the near-term driver; the outcome is not known in advance.Finnhub
- 2026-07-31Colgate India adjusted profit up 2.7%▲ BullishColgate Palmoilve (India) posted a 2.7% rise in adjusted quarterly profit on Friday, supported by growing demand for its premium segment.
- 2026-07-29Colgate India profit rises 6.9%▲ BullishThe Indian unit of U.S.-based Colgate Palmolive (CL.N) , opens new tab reported a net profit rise of 6.9% to 3.43 billion rupees ($35.84 million) for the quarter ended June 30.
- 2026-05-01Net sales up 8.4% to $5.32B▲ BullishNet sales rose 8.4% to $5.32 billion, as growth across all international divisions offset a 1.8% decline in North American sales.
- 2026-05-01Quarterly sales beat analyst expectations▲ BullishThe company reported quarterly net sales of $5.32 billion, exceeding average analysts' expectations of $5.22 billion according to data compiled by LSEG.
- 2026-01-30Adjusted EPS beat; 2026 growth guidance 2-6%▲ BullishIt posted an adjusted profit of 95 cents per share in the quarter, compared with expectations of 91 cents. The company expects 2026 net sales growth in the range of 2% to 6%, accounting for tariffs announced as of January 28 by all…
- 2025-04-25Adjusted EPS 91 cents beats estimates▲ BullishOn an adjusted basis, Colgate reported earnings of 91 cents per share, surpassing the average analyst estimate of 86 cents, as per data compiled by LSEG.
Machine-readable table — same developments, with source
Recent third-party developments classified bullish / bearish for the stock; verbatim, sourced.
| Date | Development | Direction | Source |
|---|---|---|---|
| 2026-10-30 | Next scheduled quarterly earnings report (2026-10-30). Revenue, margins and guidance are the near-term driver; the outcome is not known in advance. | ◆ Scheduled | Finnhub |
| 2026-07-31 | Colgate Palmoilve (India) posted a 2.7% rise in adjusted quarterly profit on Friday, supported by growing demand for its premium segment. | ▲ Bullish | Reuters |
| 2026-07-29 | The Indian unit of U.S.-based Colgate Palmolive (CL.N) , opens new tab reported a net profit rise of 6.9% to 3.43 billion rupees ($35.84 million) for the quarter ended June 30. | ▲ Bullish | Reuters |
| 2026-05-01 | Net sales rose 8.4% to $5.32 billion, as growth across all international divisions offset a 1.8% decline in North American sales. | ▲ Bullish | The Wall Street Journal |
| 2026-05-01 | The company reported quarterly net sales of $5.32 billion, exceeding average analysts' expectations of $5.22 billion according to data compiled by LSEG. | ▲ Bullish | Reuters |
| 2026-01-30 | It posted an adjusted profit of 95 cents per share in the quarter, compared with expectations of 91 cents. The company expects 2026 net sales growth in the range of 2% to 6%, accounting for tariffs announced as of January 28 by all… | ▲ Bullish | Reuters |
| 2025-04-25 | On an adjusted basis, Colgate reported earnings of 91 cents per share, surpassing the average analyst estimate of 86 cents, as per data compiled by LSEG. | ▲ Bullish | Reuters |
Key Takeaways
- •Colgate-Palmolive's Q2 2026 gross profit margin reached 61.5%, expanding 140 basis points year over year, reflecting pricing power and cost discipline in a competitive consumer staples environment.
- •Institutional investors held approximately 80.41% of Colgate-Palmolive shares as of mid-2026, including BlackRock's roughly 8.74% stake, indicating deep long-term ownership concentration that can dampen intraday volatility but amplify moves during institutional rebalancing.
- •The company's mid-single-digit base-business EPS growth guidance for 2026, paired with a dividend raised to $0.53 per quarter, positions CL as a classic capital-preservation name rather than a growth-momentum play.
- •First-half 2026 free cash flow before dividends of $1.48 billion against $879 million in dividends paid illustrates the company's capacity to sustain its dividend without straining liquidity.
- •Consumer staples names such as CL typically exhibit lower beta relative to the broader market, making them reference points for traders seeking defensive exposure during periods of elevated macro uncertainty.
Ownership
Top Institutional Holders
SEC 13FThe largest institutional shareholders, from SEC Form 13F filings — who holds the stock and how much.
| Institution | Shares | Value | % of shares |
|---|---|---|---|
| BlackRock, Inc. | 72.6M | $6.2B | 9.11% |
| Vanguard Capital Management LLC | 52.2M | $4.5B | 6.55% |
| State Street Corp. | 47.7M | $4.1B | 5.99% |
| Vanguard Portfolio Management LLC | 23.8M | $2.0B | 2.99% |
| Geode Capital Management, LLC | 22.9M | $2.0B | 2.87% |
| Morgan Stanley | 20.9M | $1.8B | 2.62% |
| Bank of New York Mellon Corp | 12.5M | $1.1B | 1.57% |
| Deutsche Bank Ag\ | 11.9M | $1.0B | 1.50% |
| Goldman Sachs Group Inc. | 9.5M | $807.6M | 1.19% |
| FMR LLC | 9.0M | $767.8M | 1.13% |
Source: SEC Form 13F filings · 1933 institutional holders · as of 31-MAR-2026. 13F data is quarterly and lagged (filed ~45 days after quarter-end) and covers US institutional managers (>$100M AUM) only — not insiders, retail, or foreign holders. Not investment advice.
Understand the risks
Trading Risks
An honest, up-front list of the risks — both out of respect for the trader and as a YMYL compliance requirement.
High leverage means a small adverse move can trigger forced liquidation and loss of your full margin.
A high P/E stock is very sensitive to interest-rate and narrative shifts; swings can be large.
After-hours and weekend gaps; extended-hours liquidity is thinner than the regular session.
The CFD reference price can diverge from the exchange execution price.
Price swings widen around earnings dates and other scheduled disclosures.
Recalls, policy changes, or company-specific events can cause sharp moves.
Reference
Frequently Asked Questions
Colgate-Palmolive operates through two primary reportable segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care segment is the larger of the two by revenue and includes the company's toothpaste, toothbrush, mouthwash, bar soap, liquid soap, and household cleaning product lines sold under brands including Colgate, Palmolive, and Softsoap, among others. The Pet Nutrition segment operates through Hill's Pet Nutrition, which produces prescription diet and Science Diet products sold through veterinary clinics and retail channels. Within the Oral, Personal and Home Care segment, the company further breaks down reporting by geography, covering North America, Latin America, Europe, Asia Pacific, and Africa/Eurasia. This geographic sub-structure reflects the company's strategy of adapting product formulations and brand positioning to local consumer preferences. Hill's Pet Nutrition has expanded steadily as a proportion of overall revenue, providing some diversification from the core consumer staples categories.
Glossary
Key listed-stock and CFD terms, one line each — so the page is unambiguous for both readers and AI answer engines.
| Stock CFD | A contract for difference on a share price — price exposure only, not ownership of the underlying shares. |
|---|---|
| Extended hours | Pre-market and after-hours trading outside the exchange’s regular session. |
| Basis risk | The risk that the CFD reference price and the exchange execution price do not move in step. |
| P/E | Price-to-earnings ratio = share price ÷ earnings per share; a common valuation gauge. |
| Gross margin | Gross profit ÷ revenue; reflects product-level profitability. |
| EPS | Earnings per share = net income ÷ diluted shares outstanding. |
Source Map
Every figure on this page traces to a primary or named third-party source. "As of" dates the source; "last checked" dates our most recent read of it.
Every figure here is also published as machine-readable data, and re-checked on a schedule so a stale one shows up as stale. View the raw data
| Field | Value | Source | As of | Last checked | |
|---|---|---|---|---|---|
| Reference price | live | CoinUnited stock CFD reference (live) | — | — | — |
| Market cap | $70B | CoinUnited reference x SEC shares | 2026-09-20 | 2026-09-20 | — |
| P/E | ~33.3 | CoinUnited reference / SEC annual EPS | — | 2026-09-20 | — |
| 52-week range | $74.53 – $99.31 | CoinUnited daily kline | — | 2026-09-20 | — |
| Next earnings | 2026-10-30 | Finnhub | — | 2026-09-20 | — |
| Quarterly revenue | $5.36B | SEC 10-Q | Q2 2026 | 2026-09-20 | View |
| Net income | $693M | SEC 10-Q | Q2 2026 | 2026-09-20 | View |
| Gross margin | 61.5% | SEC 10-Q | Q2 2026 | 2026-09-20 | View |
| Diluted EPS | $0.86 | SEC 10-Q | Q2 2026 | 2026-09-20 | View |
| Institutional ownership | 10 top holders | SEC Form 13F | 31-MAR-2026 | 2026-09-13 | View |
| Analyst price targets | $97.78 consensus | Aggregated sell-side analyst consensus | 2026-09-13 | 2026-09-13 | — |
| Peer valuations | 6 peers | Third-party ratios (FMP), trailing twelve months | 2026-09-13 | 2026-09-13 | — |
| Founded | 1953 | Wikidata | — | 2026-09-20 | — |
| Headquarters | New York City | Wikidata | — | 2026-09-20 | — |
| CEO | Noel Wallace | Wikidata | — | 2026-09-20 | — |
| Industry | personal care product | Wikidata | — | 2026-09-20 | — |
| CoinUnited product | Stock CFD — price exposure, not equity (no voting; dividends reflected as adjustment); leverage available | CoinUnited product terms | — | 2026-09-20 | — |
Disclaimers & References
Important Risk Disclaimer
A CoinUnited stock CFD gives price exposure to Colgate-Palmolive only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.
Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.
Users should conduct their own research and consult with qualified financial professionals before making any investment decisions. The creators and operators of this platform assume no responsibility for any financial losses or other damages that may result from reliance on the information provided.
Leveraged trading is extremely risky and you may lose your entire deposit.
Methodology Overview
Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.
- Financial statements: the company's own SEC filings (10-K / 10-Q), read from XBRL
- Market data: the CoinUnited reference price and daily closes
- Institutional ownership: SEC Form 13F quarterly filings
- Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited's view
- Peer multiples: third-party trailing-twelve-month ratios
CoinUnited does not publish a price forecast or target for Colgate-Palmolive.
Last methodology review:
Ready to Start Trading Colgate-Palmolive?
Join thousands of traders and start your Colgate-Palmolive trading journey today. Get access to advanced trading tools and competitive fees.

CL
Colgate-Palmolive
Live from CoinUnited.io